ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.（CLPT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CLPT · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
10
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
ClearPoint Neuro, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CLPT 季度内部人买卖趋势
CLPT 内幕交易卖出 · CLPT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CLPT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CLPT 高管卖出股份 · CLPT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Richards Timothy T. Director | Sale | 5,415 | $66K | Form 4 |
| May 21, 2026 | Klein Matthew B. Director | Sale | 16,000 | $185K | Form 4 |
| May 19, 2026 | Klein Matthew B. Director | Option | 12,417 | — | Form 4 |
| May 19, 2026 | FALLON LYNNETTE C Director | Option | 12,417 | — | Form 4 |
| May 20, 2026 | FALLON LYNNETTE C Director | Sale | 5,091 | $57K | Form 4 |
| May 19, 2026 | FLETCHER R JOHN Director | Option | 12,417 | — | Form 4 |
| May 19, 2026 | Richards Timothy T. Director | Option | 12,417 | — | Form 4 |
| May 19, 2026 | JOHNSON B KRISTINE Director | Option | 12,417 | — | Form 4 |
| May 19, 2026 | Girin Pascal E R Director | Option | 12,417 | — | Form 4 |
| May 19, 2026 | LIAU LINDA M. Director | Option | 12,417 | — | Form 4 |
| Apr 1, 2026 | FLETCHER R JOHN Director | Award | 1,270 | $12K | Form 4 |
| Apr 1, 2026 | Girin Pascal E R Director | Award | 755 | $7K | Form 4 |
| Apr 1, 2026 | Richards Timothy T. Director | Award | 442 | $4K | Form 4 |
| Mar 19, 2026 | BURNETT JOSEPH CEO and President · Director | Option | 20,942 | $68K | Form 4 |
| Mar 12, 2026 | D'Alessandro Danilo CFO | Option | 32,627 | — | Form 4 |
| Mar 12, 2026 | D'Alessandro Danilo CFO | Other | 16,601 | $191K | Form 4 |
| Mar 12, 2026 | BURNETT JOSEPH CEO and President · Director | Option | 84,829 | — | Form 4 |
| Mar 12, 2026 | BURNETT JOSEPH CEO and President · Director | Other | 43,161 | $498K | Form 4 |
| Mar 12, 2026 | STIGALL L. JEREMY Chief Business Officer | Option | 30,995 | — | Form 4 |
| Mar 12, 2026 | STIGALL L. JEREMY Chief Business Officer | Other | 15,151 | $175K | Form 4 |
| Mar 12, 2026 | SABRA MAZIN COO | Option | 26,101 | — | Form 4 |
| Mar 12, 2026 | SABRA MAZIN COO | Other | 13,281 | $153K | Form 4 |
| Mar 11, 2026 | D'Alessandro Danilo CFO | Option | 4,145 | — | Form 4 |
| Mar 11, 2026 | D'Alessandro Danilo CFO | Other | 2,109 | $25K | Form 4 |
| Mar 11, 2026 | STIGALL L. JEREMY Chief Business Officer | Option | 8,291 | — | Form 4 |
BURNETT JOSEPH
CEO and President · Director
日期
Mar 19
股数
20,942
均价
$3.24
总金额
$68K
BURNETT JOSEPH
CEO and President · Director
日期
Mar 12
股数
43,161
均价
$11.53
总金额
$498K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CLPT 内幕交易
CLPT 内幕交易
ClearPoint Neuro, Inc.（CLPT）内幕交易数据来源于公司内部人（包括BURNETT JOSEPH (CEO and President · Director), D'Alessandro Danilo (CFO), STIGALL L. JEREMY (Chief Business Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CLPT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ClearPoint Neuro, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CLPT 内幕交易 · 5个问题ClearPoint Neuro, Inc.（CLPT）的内部人包括高管和董事，如BURNETT JOSEPH (CEO and President · Director), D'Alessandro Danilo (CFO), STIGALL L. JEREMY (Chief Business Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026